EUVIMEDEUVIMED entdecken
Crossref

Affordability of newer antiseizure medications in Asian resource‐limited countries

Si-Lei Fong iD, Minh-An Thuy Le iD, Kheng-Seang Lim iD, Herlyani Khosama iD, Ohnmar Ohnmar iD, Say Savath, Zarine Mogal, Leonor Cabral-Lim iD, Stefanie Kar-Yan Hung, Ajay Asranna iD, Mohammad Enayet Hussain, Chiu-Wan Ng iD und 1 weitere

Epilepsia · 2023-08 · 64 (8) · 2116-2125

DOI: 10.1111/epi.17668 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Epilepsia, online erschienen am 07.06.2023. Verfasst von Si-Lei Fong und 12 weiteren Autor:innen. Beteiligte Einrichtung: Division of Neurology, Department of Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia. Hauptthemen laut MEDLINE: Anticonvulsants, Epilepsy. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 31 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

One of the objectives of the Intersectoral Global Action Plan on epilepsy and other neurological disorders for 2022 to 2031 is to ensure at least 80% of people with epilepsy (PWE) will have access to appropriate, affordable, and safe antiseizure medications (ASMs) by 2031. However, ASM affordability is a significant issue in low‐ and middle‐income countries, preventing PWE from accessing optimal treatment. This study aimed to determine the affordability of the newer (second and third generation) ASMs in resource‐limited countries in Asia.

Methods

We conducted a cross‐sectional survey by contacting country representatives in lower‐middle‐income countries (LMICs) in Asia, including Indonesia, Lao People's Democratic Republic (PDR), Myanmar, Philippines, Vietnam, India, Bangladesh, and Pakistan, and the upper‐middle‐income country Malaysia, from March 2022 to April 2022. The affordability of each ASM was calculated by dividing the 30‐day ASM cost by the daily wage of the lowest paid unskilled laborers. Treatment costing 1 day's wage or less for a 30‐day supply of chronic disease is considered affordable.

Results

Eight LMICs and one upper‐middle‐income country were included in this study. Lao PDR had no newer ASM, and Vietnam had only three newer ASMs. The most frequently available ASMs were levetiracetam, topiramate, and lamotrigine, and the least frequently available was lacosamide. The majority of the newer ASMs were unaffordable, with the median number of days' wages for a 30‐day supply ranging from 5.6 to 14.8 days. Significance All new generation ASMs, whether original or generic brands, were unaffordable in most Asian LMICs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnticonvulsantsEpilepsyHumansCross-Sectional StudiesAsiaIndiaCosts and Cost Analysis

Stichwörter der Autor:innen

Asiaaffordabilityantiseizure medicationresource-limited countries

Substanzen

Anticonvulsants

Autor:innen und Institutionen

  • Division of Neurology, Department of Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
  • Department of Neurology, Faculty of Medicine, University of Medicine and Pharmacy, Ho Chi Minh City, Vietnam.
  • Neurology Department, Faculty of Medicine, University Sam Ratulangi, Manado, Indonesia.
  • Department of Neurology, Yangon General Hospital/University of Medicine 1, Yangon, Myanmar.
  • Department of Medicine, Mittaphab Hospital, Vientiane, Lao People's Democratic Republic.
  • National Epilepsy Center, Jinnah Postgraduate Medical Center, Karachi, Pakistan.

ORCID-Profile: Si-Lei Fong, Minh-An Thuy Le, Kheng-Seang Lim, Herlyani Khosama, Ohnmar Ohnmar, Leonor Cabral-Lim, Ajay Asranna, Chiu-Wan Ng

Zitieren

APA

Fong, S. L., Thuy Le, M. A., Lim, K. S., Khosama, H., Ohnmar, O., Savath, S., Mogal, Z., Cabral-Lim, L., Hung, S. K., Asranna, A., Hussain, M. E., Ng, C. W., & Tan, C. T. (2023). Affordability of newer antiseizure medications in Asian resource‐limited countries. Epilepsia, 64(8), 2116-2125. https://doi.org/10.1111/epi.17668

Vancouver

Fong SL, Thuy Le MA, Lim KS, Khosama H, Ohnmar O, Savath S, et al. Affordability of newer antiseizure medications in Asian resource‐limited countries. Epilepsia. 2023;64(8):2116-2125. doi:10.1111/epi.17668

BibTeX
@article{Fong2023,
  author = {Fong, Si-Lei and Thuy Le, Minh-An and Lim, Kheng-Seang and Khosama, Herlyani and Ohnmar, Ohnmar and Savath, Say and Mogal, Zarine and Cabral-Lim, Leonor and Hung, Stefanie Kar-Yan and Asranna, Ajay and Hussain, Mohammad Enayet and Ng, Chiu-Wan and Tan, Chong-Tin},
  title = {Affordability of newer antiseizure medications in Asian resource‐limited countries},
  journal = {Epilepsia},
  year = {2023},
  volume = {64},
  number = {8},
  pages = {2116--2125},
  doi = {10.1111/epi.17668}
}
Kostenlos starten →